The Clinician Partners with Queensland Health for Statewide Implementation of Patient Reported Measures and Patient Safety Culture Surveys

BRISBANE,Australia,Oct. 15,2024-- The Clinician has been awarded a statewide contract by Queensland Health to implement theirZEDOC platform. This platform will enhance the collection and analysis of P

Industrial Heat Pumps: A Key Driver for Decarbonising Industrial Heat in the Industrial Electrification Era

Unlocking opportunities that exist at higher temperatures will be key to future growth LONDON,Oct. 14,2024-- The need to reduce the demand for fossil fuels in industrial applications is driving invest

Why Asian Insurers Must Act Now: A Podcast on The Innovation That's Disrupting the Industry

SINGAPORE,Oct. 15,2024--In the latest episode of the Asia InsurTech Podcast,the co-founder of Novo AI,a strategic partner of April Insurance and Tokio Marine,shed light on the growing concerns over ho

Introducing TuniTuni to Malaysia: Korea's No. 1 Storytelling Play Gym Now Open in Kuala Lumpur

KUALA LUMPUR,Malaysia,Oct. 15,2024-- With the arrival of TuniTuni,Korea\'s No. 1 storytelling play gym,a world of adventure and learning awaits young children in Malaysia. Launching its first center i

The "Giant Panda Fans Tour to Sichuan" event launches 10 unique cultural tourism consumer products globally with new styles

Shijingshan: Committed to High-Level Openness

BEIJING,Sept. 22,2024-- Following the third plenary session of the 20th Central Committee of the Communist Party of China,China successfully hosted its first national-level international large-scale f

Manufacturing in Anhui: Advancing Towards Higher-Quality Development through Transformation and Upgrading

HEFEI,China,Sept. 22,2024-- In recent years,Anhui,a province in eastern China,has been pursuing high-quality development across the entire spectrum of new industrialization and endeavoring to make man

Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

HANSIZHUANG (serplulimab) is the world\'s first anti-PD-1 mAb for first-line treatment of ES-SCLC - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody ava

Gymera Reveal A Breakthrough in Smart Home Fitness and Elderly Wellness Solution at Hong Kong Global Sources Consumer Electronics Show 2024

SHENZHEN,China,Sept. 21,2024-- In today\'s fast-paced world,maintaining health and vitality has become increasingly important,especially in home fitness and eldercare scenarios. Gymera proudly introdu

Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results

YANGZHOU,China,Sept. 21,2024-- Meihua International Medical Technologies Co.,Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA),a reputable manufacturer and provider of Class I,II,and I